Mycoplasma Testing Market Size, Share & COVID-19 Impact Analysis, By Testing Method (PCR-based, Culture-based, and Others), By Product (Instruments and Reagents & Kits), By Application (Cell Culture, Virus Testing, Vaccine Testing, and Others), By End-user (Biopharmaceutical & Biotechnology Companies, Cell banks, Contract Research Organizations & Contract Manufacturing Organizations, and Others), and Regional Forecast, 2023 - 2030

ATTRIBUTE

DETAILS

Study Period

2019-2030

Base Year

2022

Estimated Year  

2023

Forecast Period

2023-2030

Historical Period

2019-2021

Growth Rate

CAGR of 5.1% from 2023 to 2030

Unit

Value (USD Million)

Segmentation

By Testing Method

• PCR-based
• Culture-based
• Others

By Product

• Instruments
• Reagents & Kits

By Application

• Cell Culture
• Vaccine Testing
• Virus Testing
• Others

By End-user

• Biopharmaceutical & Biotechnology Companies
• Cell banks
• Contract Research Organizations & Contract Manufacturing Organizations
• Others

By Region

• North America (By Testing Method, Product, Application, End-user, and By Country)
  • U.S. (By Testing Method)
  • Canada (By Testing Method)
• Europe (By Testing Method, Product, Application, End-user, and Country/Sub-region)
  • U.K. (By Testing Method)
  • Germany (By Testing Method)
  • France (By Testing Method)
  • Italy (By Testing Method)
  • Spain (By Testing Method)
  • Rest of Europe (By Testing Method)
• Asia Pacific (By Testing Method, Product, Application, End-user, and Country/Sub-region)
  • China (By Testing Method)
  • Japan (By Testing Method)
  • India (By Testing Method)
  • Australia (By Testing Method)
  • Southeast Asia (By Testing Method)
  • Rest of Asia Pacific (By Testing Method)
• Rest of the World (By Testing Method, Product, Application, and End-user)